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ABSTRACT
Reproducibility of alkaline inorganic phosphate quantification using 31P-Magnetic
Resonance Spectroscopy at 3T
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INTRODUCTION: The detection of a second inorganic phosphate (Pi) resonance, a possible
marker of mitochondrial content in vivo, using phosphorus magnetic resonance spectroscopy (31PMRS) at 3T is technically challenging, which may prevent its reproducible quantification.
PURPOSE: To determine the reproducibility of resting alkaline inorganic phosphate (Pialk)
measurement using 31P-MRS in human skeletal muscle at 3 tesla (T). METHODS: Resting 31PMRS of the quadriceps muscles was acquired on two separate visits, within seven days, in 13
healthy, sedentary to moderately active young adults using a whole-body 3T MR system.
Measurement variability related to coil position, shimming procedure, and spectral analysis were
also quantified. 31P-MRS data were acquired with a 31P/1H dual-tuned surface coil positioned on
the quadriceps using a pulse-acquire sequence. Test-retest absolute and relative reproducibility
were analyzed using coefficient of variation (CV) and intra-class correlation coefficients (ICC),
respectively. RESULTS: Pialk demonstrated a within-subject reproducibility marginally greater
then the 10% cutoff (CV: 10.6 ± 5.4%; ICC: 0.80), but still appropriate given its small
concentration in relation to other 31P metabolites. Proximo-distal change in coil positioning along
the length of the quadriceps induced large variability in Pialk quantification (CV: 21.1%). In
contrast, measurement variability due to repeated shims on consecutive scans from the same
muscle sample (CV: 6.6%), and the automated spectral processing procedure, were minor (CV:
2.3%). Both metrics of absolute and relative reproducibility of Pialk were of similar magnitude to
other well-resolved metabolites (e.g., phosphocreatine, Pi, and phosphodiester). CONCLUSION:
Using multiple metrics, the present study established the high reproducibility of Pialk quantification
by 31P-MRS using a surface coil on the quadriceps muscle at 3T. However, large variability in Pialk
quantification can originate from positioning the coil on the most distal part of the quadriceps,
which should be avoided due to shimming inhomogeneity.
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CHAPTER I
INTRODUCTION
1.1 Background
Since its early development in the 1970’s, phosphorus magnetic resonance spectroscopy (31PMRS) has been integral to the study of skeletal muscle bioenergetics. This technique allows
phosphate metabolites, e.g., adenosine triphosphate (ATP), to be characterized in vivo (see
representative spectra in Figure 1.) (1–3). A typical

31P-MRS

spectrum displays six prominent

peaks corresponding to the three phosphate groups of ATP, phosphocreatine (PCr), the
phosphodiesters (PDE) glycerophosphoethanolamine (GPE) and glycerophosphocholine (GPC),
and inorganic phosphate (Pi), of which the area under the curve provide a measure of metabolite

Figure 1. A typical 31P MR spectrum of the resting soleus muscle of a healthy young male volunteer. Peak assignments: two signals
for inorganic phosphate (Pi1: cytosol; Pi2: mitochondrial matrix), the phosphodiesters (PDE) glycerol phosphocholine (GPC) and
glycerol phosphoethanolamine (GPE), phosphocreatine (PCr), three signals for ATP and pyridine nucleotides (NADPH). As
excerpted from Kan et al., 2010.
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concentration. The temporal changes in pH, Pi, and phosphocreatine (PCr) during and following
an exercise have been extensively used to investigate several key aspects of muscle bioenergetics
such as ATP turnover rate, proton handling, and mitochondrial function (4–6). Given the central
role of high-energy phosphate metabolites in bioenergetic processes, 31P-MRS has been essential
to improving our understanding of skeletal muscle metabolism during the last four decades.
In recent years, the field of muscle bioenergetics has seen a renewed interest for skeletal
muscle metabolites with a concentration at the limit of detection of 31P-MRS, such as nicotinamide
dinucleotide (NAD+) and alkaline Pi resonance (Pialk), given their potential as markers of redox
balance and mitochondrial content, respectively. In regard to the latter metabolite, in the 1970’s
(7, 8) and early 1980’s (9–12), researchers first characterized two Pi pools in intact cells and
mitochondria using high-resolution

31P-MRS

at ultra-high fields (>7 Tesla). Specifically, a

discernible doublet Pi peak could be detected in the MRS spectra, with the upfield (lower
frequency) peak attributed to the cytosolic compartment (Picyt), and downfield (higher frequency)
more alkaline peak attributed to the mitochondrial matrix (Pialk) (7, 8, 10, 13–15). The pH of this
more alkaline Pi pool was indeed consistent with the mitochondrial matrix pH ranges (~7.4 to 8.2)
(7, 8, 16) measured in vitro and to parallel the changes in mitochondrial volume. Subsequently,
the observation of two separate pools of Pi was extended to intact perfused cardiac muscle (10,
13) and rat liver (14, 15).
Recent technological advancements in MR, most notably the development of ultra-high
field 7T whole-body scanner, which provides higher spectral dispersion and signal-to-noise (SNR)
ratio (17), has led to a renewed interest in detecting this second alkaline Pi pool in the skeletal
muscle in vivo(1–3, 18, 19). Kan et al., (2010) were the first to detect Pialk in intact resting soleus
and tibialis anterior (TA) muscle, which was then confirmed in the quadriceps femoris (2), vastus
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lateralis muscle (1, 19), and brain (18). Importantly, several results in vivo corroborated the
original notion of the mitochondrial origin of Pialk. For example, expressed as Pialk/Picyt, a
significantly lower ratio was documented in the TA (P ialk: 0.07; ~70% slow oxidative fibers) as
compared to the soleus (Pialk: 0.11; ~90% slow oxidative fibers) (3), thus suggesting a greater
mitochondrial volume-density in the soleus, consistent with in vitro findings (20, 21). Likewise,
aerobically trained athletes exhibited a higher Pialk/Picyt ratio (0.07) in the quadriceps muscle than
recreationally active adults (0.03) (1). Pialk further correlated (r = 0.68) with the maximal rate of
oxidative ATP synthesis (Vmax) as measured by 31P-MRS in obese-to-sedentary patients (2). Taken
together, these data suggest that Pialk may be a non-invasive surrogate marker of mitochondrial
content.
Despite the far-reaching consequences of using this non-invasive marker for the diagnosis
of clinical conditions and for the study of human metabolism, several challenges have limited its
translational impact so far. Only recently (as of 2017) have 7T scanners been approved for clinical
settings and these MR systems are currently limited to only a few research centers in the world.
While 3 Tesla MR systems are more widely available, reliably detecting Pialk at this lower magnetic
field represents a major undertaking, which may explain some of the inconsistencies in the results
and controversies regarding the origin of the Pialk peak (19, 22, 23). Indeed, the chemical shift
between Picyt and Pialk is only ~0.4 ppm, and Pialk concentration in the skeletal muscle is <1mM,
i.e., at the limit of sensitivity of the 31P-MRS technique using standard sequence in vivo, which
complicates its quantification (3). To date, a reproducible method to quantify Pialk in the skeletal
muscle using 31P-MRS with a 3T whole-body MR system has yet to be established as it represents
an important first step toward the translation of this potential surrogate marker of mitochondrial
content into clinical practice.
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The goal of this project was to quantify the reproducibility of Pialk measured at 3T by a surface
coil in the skeletal muscle using a

31P-MRS

technique. Specifically, we quantified the within-

subject reproducibility of [Pialk] with a surface coil on the quadriceps using 31P-MRS by calculating
both the relative and absolute reproducibility of [Pialk] in sedentary to moderately active young
adults. We also determined the contribution from changes in coil location, shimming procedure,
and spectral processing by an automated software to the measurement variability of [Pialk].
1.2 Aims and Hypotheses
1.2.1

AIM I: To determine the within-subject test-retest absolute and relative reproducibility of
31P-MRS-derived

Pialk at 3T in resting quadriceps muscle of sedentary-to-moderately

active young adults.
HYPOTHESIS IA: [Pialk] would demonstrate high absolute (coefficient of variation) and
relative reproducibility (intra-class coefficient of correlation).
HYPOTHESIS IB: These metrics would be lower than other well-resolved phosphorus
metabolites (e.g., PCr, Pi, PDE) detected in the skeletal muscle.
1.2.2

AIM II: To determine the contribution to [Pialk] measurement variability from changes in
coil location, repeated shimming, and spectral processing by an automated software
procedure (CSIAPO).
HYPOTHESIS IIA: Based upon prior studies (24), we hypothesized that coil location
would substantially influence [Pialk] reproducibility.
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HYPOTHESIS IIB: We hypothesized that absolute reproducibility from 10 consecutive
scans of the same muscle region would be high.
HYPOTHESIS IIC: We hypothesized high absolute reproducibility from 20 consecutive
spectral analysis of the same spectra using an automated software by the same investigator.
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CHAPTER II
LITERATURE REVIEW
This literature review will first provide an overview of the skeletal muscle mitochondrion.
Emphasis will be consigned to structural parameters; namely, the primary constituents of the
energy transduction pathway, membrane phosphatides, and genomic material (mitochondrial DNA
[mtDNA]). Secondly, using exercise as a physiological stimulus, mitochondrial adaptations will
be examined within the framework of morphometry. An argument for the importance of reliably
quantifying mitochondrial content will be put forward. Thirdly, current in vitro surrogates of
mitochondrial content, and their inherent limitations, will be surveyed. Provided no wellestablished in vivo surrogate marker exists, this review will conclude with an inquiry on a novel
technique, and biomarker, of mitochondrial content:

31P-MRS-derived

alkaline inorganic

phosphate (Pialk), which has been hypothesized to originate from the mitochondrial matrix and
may represent a promising clinical/research tool in the field of bioenergetics.
2.2. The Mitochondrion
2.2.1

The skeletal muscle mitochondrion
The mitochondrion is commonly depicted as a dynamic, semi-permeable, double-

membrane reticular organelle. A unique mitochondrial inner membrane (IMM) phosphatide,
cardiolipin, is characterized by its four linoleic acid groups linked by a glycerol backbone
(resembling two fused phospholipids; see Figure 2.) and is essential to maintain membrane
integrity and stabilization of complex proteins. The inner mitochondrial membrane (IMM)
invaginates inwards, creating a distinct pattern of folds called ‘cristae’, that collectively comprise
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the mitochondrial matrix. Enclosed within the IMM and outer mitochondrial membrane (OMM)
is the intermembrane space (IMS).

Figure 2. The structure and location of cardiolipin within the innermitochondrial membrane (IMM). Note its consolidation near
complex proteins, thereby providing support, membrane integrity, and consequently, improving respiratory function.

A composite respiratory chain of multipolypetide enzymes (Complexes I-IV) are
embedded within the IMM, collectively termed ‘electron transport chain (ETC)’. Adjacent to the
IMM complex proteins, in the matrix space, is a mitochondrial-exclusive metabolic pathway: the
‘tricarboxylic acid cycle’ (TCA; Figure 5.). Dehydrogenase activity of TCA enzymes is the source
of reducing equivalents, which donate electrons at Complex’s I and II. A redox potential across
ETC proteins, with oxygen (O2) as the final electron acceptor, drives the transmembrane
electrochemical proton motive force coupled to ATP Synthase (i.e., Complex V) to generate ATP
by phosphorylation of adenosine diphosphate (ADP) (Figure 3.).
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Figure 3. The structure and function of the electron transport chain (ETC) and tricarboxylic acid cycle (TCA). Note Complex I-IV
and ATP Synthase driving electron flow and ATP synthesis. Reducing equivalents (NADH and FADH2) from TCA donate electrons
at Complex I and II, respectively. Oxygen is the final electron acceptor, and a transmembrane proton gradient is established. Note
the location of TCA in relation to the electron transport chain (ETC). The condensation of Oxaloacetate to Citrate, by Citrate
Synthase, produces the coenzyme A (CoA) necessary for adequate flux of TCA, and is thus a rate determining enzyme.

2.2.2

Mitochondrial content
Mitochondria exhibit morphologic plasticity in response to stressors (e.g., low energy

levels, hypoxia, exercise, oxidative stress, etc.) and their shapes change continually through the
combined action of fission, fusion, and motility. Accordingly, mitochondrial function depends on
19

the organelle’s structure, and the organelle’s structure is, in turn, controlled by cell function.
Research in the field has therefore focused on quantifying ‘mitochondrial content’, which refers
to the concentration, area occupied, or density, of mitochondria in a given sample volume (e.g.,
tissue biopsy). Mitochondrial density has traditionally been quantified as mitochondrial number or
fractional area using transmission electron microscopy (TEM) techniques (25). The former is
simply the number of mitochondria in a given area of myofiber whereas the latter also accounts
for the mass fraction of the mitochondria, such that increased fractional area can be a product of
more mitochondria (i.e., number) or larger mitochondria (i.e., volume). Fractional area further
relates to the three-dimensional reticular nature of the mitochondria governed by dynamic fission
and fusion machinery (26–29).
The need for specialized equipment and technical expertise to perform microscopic
imaging of the mitochondria has fostered the use of alternative surrogate markers of mitochondrial
content. For instance, spectrophotometric assessment of oxidative enzymes, in particular the TCA
enzyme citrate synthase (CS) and cytochrome-c oxidase, and other structural components of the
mitochondrial (e.g., mitochondrial complexes I-V, cardiolipin) and genomic (e.g., mitochondrial
DNA) machinery have been used in lieu of TEM as mitochondrial markers (30). The diverse
repertoire of morphometric measurements underscores the importance of reliably quantifying
mitochondrial content, particularly as this normalization provides important insight into the
intrinsic properties of the mitochondria. In the context of the present proposal, mitochondrial
content will refer to mitochondrial fractional area (or volume density).
2.2.3. Mitochondrial plasticity: training-induced adaptations as a paradigm
Increased mitochondrial content is a well-established adaptation to aerobic endurance
exercise training(31–34). For instance, rats subject to chronic aerobic running exhibited a two-fold
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increase in gluteal m. cytochrome c oxidase (33). This was not muscle specific, as a similar
magnitude increase in cytochrome c oxidase and succinate dehydrogenase was also documented
in the gastrocnemius-soleus complex of the same rats. Likewise, in humans, comparative analysis
of the skeletal muscle of endurance (VO2max: 76.1 ml/kg/min) and recreational (VO2max: 61.3
ml/kg/min) male athletes revealed a 1.47-fold and 1.20-fold increase in mitochondrial density and
size, respectively, in endurance athletes (35). Jacobs and Lundby (2013) further characterized the
training dose-response of mitochondrial content among individuals of different training levels (see
Figure 4.). Stratified by active (51.2 ± 4.1 ml·kg-1·min-1), well-trained (63.9 ± 4.7 ml·kg-1·min-1),
highly trained (71.3 ± 1.7 ml·kg-1·min-1), and elite athletes (77.3 ± 3.0 ml·kg-1·min-1), CS activity
increased as a function of training status.

Figure 4. (A) Aerobic capacity, expressed as relative maximal oxygen consumption (VO2max), across groups. (B) Citrate synthase
(CS) activity as a biomarker of mitochondrial content across groups. AT, active; WT, well-trained; HT, highly trained; ET, elite. *
significance of p<0.05. As excerpted from Jacobs & Lundby, 2013.

2.2.4. Training-induced adaptations to mitochondrial function
The observation that mitochondrial content increases following exercise is strongly related
to improvements in mitochondrial function. For example, in the same study by Jacob and Lundby
(2013), mass specific respiratory capacity significantly increased with training status (see Figure
5.). ETC capacity, and importantly, maximal state 3 respiration (P), an index of the mitochondria’s

21

ability to sequentially catalyze redox reactions coupled to ATP synthesis, was superior in the ET
group and a strong predictor of cardiorespiratory fitness (CRF; see Figure 5A.)

Figure 5. Mitochondrial respiration control across groups. A: mass-specific respiratory capacity. B: mitochondrial-specific
respiratory capacity across groups. LN, leak respiration in absence of adenylates; PETF, maximal electron flow through electrontransferring flavoprotein (ETF) and fatty acid oxidative capacity; PC1, submaximal state 3 respiratory capacity specific to complex
I; P, maximal state 3 respiration and oxidative phosphorylation capacity; ETS, electron transport system capacity; PC2, submaximal
state 3 respiratory capacity specific to complex II. Values are means ± SD. Significant difference of *p<0.05, **p<0.01, and
***p<0.001. As excerpted from Jacobs & Lundby, 2013.

Relationship between mitochondrial content and function
Comparative physiology among mammalian species provides a unique perspective on the
interplay between structure and function, which has led to the formulation of the symmorphosis
theory (36). Simply, symmorphosis states that in any organism, regulation of the biological units,
namely, functional and structural parameters, are tightly matched to optimize systemic function.
Interestingly, using this conceptual framework, mitochondrial volume (Vmt) was closely linked to
body mass specific VO2max across species (30, 37, 38). Likewise, metabolically superior species
(defined as having an above average VO 2max) within the same size class also exhibit matched
increase in mitochondrial volume (see Figure 6.). Interestingly, CS activity also correlated
accordingly with muscle tissue types of differing oxidative profiles, from cardiac (high oxidative
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capacity; 222 ± 13 µmol·g-1·min-1), skeletal (115 ± 2 µmol·g-1·min-1), and smooth muscle (48 ± 2
µmol·g-1·min-1) (39).

Figure 6. Whole-body VO2 (A) and allometric plot of VO2 per mitochondrial volume, V(mt), (B) for species ranging in mass from
16g to 450kg. The open triangles indicate data from humans considering total muscle mass and ‘active’ muscle mass (filled
triangle). Mb; body mass. As excerpted from Hoppeler & Weibel, 1998.

Together, these findings suggest that augmented mitochondrial content-volume appears to be
responsible for the increased tissue-specific aerobic capacity for ATP synthesis. However, upon
closer inspection, it appears that mitochondrial content and function can sometimes be dissociated,
thus reflecting intrinsic changes in mitochondrial function. For instance, when normalized to
mitochondrial content (i.e. CS activity in this study), mitochondrial respiration remained superior
in elite athletes, suggesting an improved intrinsic capacity for ATP synthesis or “mitochondrial
quality” (see Figure 5B.) (40). The magnitude of the changes in mitochondrial respiration with
endurance training is greater than can be expected from the changes in mitochondrial content (41)
(see Figure 7). Lastly, short-term bed rest result in decreased mitochondrial content, but preserved
respiration such that intrinsic mitochondrial respiratory capacity is paradoxically increased (42).
Therefore, the ability to determine the effects of a condition on intrinsic mitochondrial function is
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contingent on normalizing to quantitative measures of content. Accordingly, assessments of
mitochondrial content are imperative to accurately monitor pharmacological and nonpharmacological treatment interventions. For these reasons, there has been an impetus to identify
reliable assessment techniques of mitochondrial content.

Figure 7. Mitochondrial respiration and citrate synthase activity in humans of differing training status. SED; Sedentary, ACT;
Active, TRA; Trained, MT; Moderately-Trained, WT; Well-Trained, HT; Highly-Trained. As excerpted from Bishop et al., 2013.

2.3. Current assessment techniques of mitochondrial content
Transmission electron microscopy (TEM), which provides fine resolution structural data of the
mitochondrial network is considered the “Gold Standard” for the quantitative assessment of
mitochondrial content (30, 43). However, biological surrogate markers of mitochondrial content
have been identified and validated. This section will briefly outline methodological considerations
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of each assessment technique of mitochondrial content. Finally, a novel in vivo surrogate technique
will be presented, and a justification for its significance and applicability will be advanced.
2.3.1

Gold Standard: Transmission Electron Microscopy
The advent of TEM in the early 1940’s was integral for the field of cell biology as the

intricacies of the cellular structure were being elucidated (44).
Technical Consideration: TEM exploits the electrochemical properties of electrons. Briefly, short
wavelength (on the order of 100,000-fold shorter than visible light) electron beams are diffused
across thin stained cell samples, and the absorptive and scattering characteristics captured to obtain
contrast image (see Figure 8.) (45). The short wavelength of the electrons with TEM allows for
Figure 8. Schematic of a standard transmission electron microscopy (TEM)
technique. Note how short-wavelength electron beams are transmitted
through a small specimen sample (corresponding to point P) and then
filtered through a lens. The diffraction and scattering of the electrons is then
captured on a neighboring imaging plate (corresponding to point R) to
obtain contrast image as a micrograph. As excerpted from Urban 2008.

fine, subnanometer resolution, optimal for the discrimination of subcellular structures
(mitochondria) and even intra-mitochondrial structures (i.e., cristae density). Specifically, the
technique of stereological point counting has been widely utilized to calculate mitochondrial
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volume density from TEM-derived micrographs (46). Briefly, an A (length) X B (height) grid is
superimposed on a two-dimensional image and the intersection of lines defined as a point.
Therefore, the percentage of mitochondria in a given muscle sample is given by the following
equation:
𝑀𝑖𝑡𝑜𝑐ℎ𝑜𝑛𝑑𝑟𝑖𝑎𝑙 𝑃𝑜𝑖𝑛𝑡 𝐼𝑛𝑡𝑒𝑟𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑠
𝑇𝑜𝑡𝑎𝑙 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑃𝑜𝑖𝑛𝑡𝑠
Recently, using a rigorous experimental design, Broskey et al., 2013 demonstrated that a total of
at least ~100-200 points is necessary to reliably estimate mitochondrial fractional volume, alluding
to the time-intensive nature of this approach. Representative TEM images of two skeletal muscle
tissue samples of different mitochondrial volumes are illustrated in Figure 9.

Figure 9. Representative electron microscopy images and western blots of complex I-V. Images and blots are from the two
subjects with the lowest mitochondrial content (A) and second highest mitochondrial content (B). (C.) Representative image used
for measuring cristae surface area. A and B are x20,000 magnification; scale bars are 1 µm. C is x80,000 magnification and scale
bar is 200 nm. White arrows show examples of outer membrane and cristate. As excerpted from Larsen et al., (2012).

Specific Limitations: Although 2D-TEM is considered the gold standard technique, it is not
without limitations. Firstly, it is widely accepted that the mitochondrial network exists as a threedimensional structure (27, 29); however, TEM is constrained to two-dimensional cross-sectional
images. Methodologically, TEM-derived images are confined to small samples (few mg) and
require the use of fixed in vitro samples, which can be a source of artifacts. Lastly, TEM is time
intensive, and requires specialized equipment and technical expertise. To circumvent these
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challenges, other surrogate markers of mitochondrial content have been used in the field of
mitochondrial physiology.
2.3.2

Surrogate markers of content

Citrate Synthase
Technical Consideration: Citrate Synthase (CS) is a mitochondrial specific enzyme responsible
for an important, flux determining, catalytic step of the TCA cycle; condensation of acetylcoenzyme A (acetyl-CoA) with oxaloacetate (Figure 3.), with the end product citrate (47). TCA is
the primary source of the reducing equivalents nicotinamide adenine dinucleotide (NADH) and
flavin adenine dinucleotide (FADH) which provide the electrons and hydrogen ions for the proton
motive force of ETC. Therefore, by regulating TCA rate, CS indirectly, is responsible for ATP
synthesis and its activity has become a widely used surrogate marker of mitochondrial content(30).
Cytochrome-c-oxidase activity, which is considered to be the rate limiting step of the electron
transport chain, is also sometimes used in lieu of CS activity (33).
Specific Limitations: Conceptually, CS activity reflects a reaction rate through the Krebs cycle
and therefore is a functional assay rather than a morphometric index of mitochondrial content.
Although similar turnover rates for different mitochondrial proteins had originally been observed,
it has recently been argued that mitochondrial enzymes exhibit independent protein turnover rates,
with a 5-fold difference in synthesis rate (43). It would therefore be erroneous to extrapolate
changes in CS activity alone to mitochondrial content.
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Complex I-V Protein Complexes
Technical Consideration: Like CS, complex proteins I-V are mitochondrial-exclusive, and both
their protein expression and activity has been used as surrogate of mitochondrial content (see
Figure 3.).
Specific Limitations: Similar to CS, incongruent expression of different mitochondrial complex
proteins may confound this assessment of mitochondrial content. This is important in light of the
fact that specific antibodies are used to assay complex proteins, often limited to one or two, while
complexes are large and composed of multiple distinct proteins.
Cardiolipin
Technical Consideration: Cardiolipin (CL) is a mitochondrial-specific, tetra-acyl phospholipid
located predominantly in the IMM. Its close proximity to ETC proteins allows CL to stabilize
complex enzymes, even directly participating in proton translocation via cytochrome bc1
(coenzyme Q:cytochrome c-oxidoreductase or complex III, see Figure 3.), thus maintaining
respiratory function. At higher respiratory rates, CL facilitates membrane integrity by preventing
osmatic instability and uncoupling.
Specific Limitations: CL quantification requires the isolation of Cl from other mitochondrial
phosphatides, which has posed a challenge to researchers (48). Firstly, with the exception of
cardiac tissue and isolate mitochondria preparations, CL is proportionally less abundant than other
phospholipids. Real-time CL detection is further constrained by their lack of conjugated double
bonds, which require costly and technically difficult mass spectrometry techniques.
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Mitochondrial DNA (mtDNA) Copy Number
Technical Consideration: According to the gene dosage theory, the expression of genes is
proportional to their copy number and thus mtDNA replication is thought to play a key role in
determining the magnitude of the changes in mitochondrial volume, content, and enzymatic
activities (49–51). Indeed, mtDNA codes for 13 polypeptides of the ETC; therefore, proteins
encoded by the mitochondrial genome, to some degree, are independently regulated by mtDNA
copy numbers (52).
Specific Limitations: A key limitation of mtDNA is that multiple factors downstream of gene
expression can influence mitochondrial content (52). Transcription factors independent of gene
expression have been shown to regulate mitochondrial content. Furthermore, post-translational and
-transcription control, and the efficiency by which these regulatory pathways function, has been
implicated in mitochondrial protein and enzyme content. Furthermore, mtDNA copy number
exhibits marked inter-individual heterogeneity (4-6 copies per cell) which could reduce statistical
power.
To illustrate the quantitative differences between these different approaches, Table 1 summarizes
the magnitude of the changes in mitochondrial content reported by different laboratories in
response to aerobic exercise training in humans (53–59).
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Table 1. Effect of moderate intensity endurance training on biomarkers of mitochondrial content in older men and women

Reliability of surrogate markers & common limitations
A key study by Larsen et al. comprehensively assessed several surrogate markers of
mitochondrial content; namely, citrate synthase (CS), cardiolipin, and complex I-V protein content
and activity, and validated their sensitivity with gold standard TEM (30). All data were derived
from the vastus lateralis muscle of young, healthy males, who represented a large range of aerobic
exercise capacities (range: 29.9-71.6 ml/min/kg), and likewise, variations in mitochondrial content
(as determined by fractional area; range: 0.04-0.15 µm2 µm-2). Hence, the heterogeneity of the
sample population provided adequate statistical power to detect sensitivity across biomarkers.
Cardiolipin demonstrated the strongest correlation (r = 0.86; p<0.001; Figure 10A.) and
highest concordance (Rc = 0.85) (within the range of ‘almost perfect’) with TEM, and rivaled CS
activity. CS demonstrated the second highest correlation (r = 0.84; p<0.001; Figure 10B.) and
concordance (Rc = 0.80) with TEM. Unlike CS activity and CL, only moderate correlations, and
concordance deemed ‘substantial’, were documented for Complex I, II, and IV activity and
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Complex II and V protein content (see Figure 10C-F.). Furthermore, among all markers examined,
mtDNA exhibited no correlation (r = 0.35; p = 0.23) or concordance with TEM (see Figure 10G.).

Figure 10. Correlation Plots. Correlation between the relative variation of the mitochondrial content and the
six biomarkers (A-F) of mitochondrial content that showed the highest Lin’s concordance coefficient (Rc) and
two biomarkers of certain interest (G and H). Continuous lines represent the perfect linear fit (slope = 1) and
dashed lines represent the actual linear fit. The linear fit was only shown when significance was present. As
excerpted from Larsen et al., 2012.
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Although the aforementioned mitochondrial biomarkers have been validated(30), and are
structurally and functionally unique, they still share major limitations, primarily derived from their
in vitro nature. Both TEM and biochemical surrogates require tissue biopsies, which are invasive,
deterred in clinical settings, and difficult to implement in frail populations (i.e., aging and disease).
Homogenization, permeabilization, and importantly, fixation procedures, required for enzyme
assays and TEM, disrupt mitochondrial structural integrity and viability. Accordingly, there is an
incentive for research into an alternative non-invasive, in vivo surrogate of mitochondrial content.
2.4 A novel assessment technique of mitochondrial content
Phosphorus (31P) MRS provides an avenue to study metabolism in intact tissue samples,
animals, and humans in vivo. The ensuing sections will examine the metabolic data derived from
31P-MRS

in isolated mitochondria, cells, perfused organs, and whole muscle. This review will

conclude with an inquiry on a novel, in vivo mitochondrial surrogate biomarker: alkaline inorganic
phosphate (Pialk).
2.4.1

MRS cell metabolism: MR spectroscopy of skeletal muscle
Phosphorus magnetic resonance spectroscopy (31P-MRS) is a non-invasive technique that

provides a unique window into the in vivo biochemistry of tissue by measuring the concentrations
and turnover rates of high-energy phosphates. Since its first application in skeletal muscle(60), this
technique has become the cornerstone for the study of muscle bioenergetics and mitochondrial
function in vivo (61–63). Typical

31P-MRS

spectra display six clearly detectable peaks

corresponding to the three phosphate groups of ATP, PCr, and PDE (see Figure 1.). In resting
muscle using a relatively long inter-pulse delay (>2-3 s), a well-resolved single inorganic
phosphate (Pi) signal originating from the cytoplasm can be detected (1–3, 7, 10, 11, 13, 14, 16,
64). In this condition, Pi is in equilibrium between the mono- and di-protonated forms with an
33

extremely fast chemical exchange between the base and acid forms, such that the Pi signal displays
a single resonance.
Interestingly, recent development of the ultra-high magnetic field (>7T) scanner has
revealed the existence of an alkaline Pi signal (Pialk) in the skeletal muscle of humans, tentatively
attributed to originate from the mitochondrial matrix (3). Early work in the field of 31P-MRS has
indeed discriminated an alkaline Pi resonance in isolated mitochondria (8, 16), which later was
detected in perfused liver (7, 15, 65) and heart extracts (10, 13). For almost two decades, Pialk has
been largely overlooked in humans, perhaps due to its short longitudinal relaxation time (T1 < 1.5s)
(3, 8, 14, 16), low concentration (<1 mM), and proximity with the predominant cytosolic Pi peak.
Although debated (19, 23), other studies conducted at ultra-high magnetic fields have confirmed
the existence of Pialk in skeletal muscle and further revealed a relationship between [Pialk] and
dynamic markers of mitochondrial function (1, 2). Accordingly, this metabolite application as a
potential surrogate biomarker of mitochondrial content has recently garnered attention (66).
2.4.2

MRS cell metabolism: The pH gradient and pH dependence of Pi
The semipermeable nature of the IMM to ions, most importantly H+, has provided a unique

opportunity for researchers to experimentally investigate the origin of the second inorganic
phosphate resonance peak. The mitochondrial matrix is indeed characterized by a low buffering
capacity (67), and therefore, mitochondrial pH mainly reflects the balance between proton
pumping by the respiratory complexes and proton re-entry across ATP synthase (see Figure 3.).
Specifically, pH is estimated in the range of 7.5-8.2 in isolated mitochondria (68, 69) and 7.4-7.8
in intact cells (67, 70). In contrast, basal cytosolic pH is more acidic, in the range of ~7.0-7.1 (7).
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Based upon this established pH gradient between the mitochondrial matrix and cytosol,
and the pH dependence of the Pi chemical shift, studies have experimentally manipulated
mitochondrial pH to discriminate the origin of the alkaline inorganic phosphate resonance. Firstly,
treatment with proton ionophores (e.g., p-trifluoromethoxyphenylhydrazone (FCCP), nigericin) to
induce proton influx, thereby acidifying the matrix, and abolishing the transmembrane proton
gradient (i.e., decrease ∆pH), collapsed the second Pi peak at 37 ˚C in hepatocytes (7) and perfused
hearts (10, 13) (see Figure 11.). Contrary, treatment with valinomycin, a potassium-ionophore that
promotes the influx of not only potassium, but also Pi, induces mitochondrial swelling,
alkalization, and subsequently, splitting of the alkaline and acidic Pi resonances.

Figure 11. Changes in cytosolic and mitochondrial pH in isolated liver cells derived from NMR spectra. The high pH
resonance is identified as mitochondrial Pi (Open Square); the lower pH resonance is assigned to the cytosolic Pi (Circle).
Arrows denote the addition of valinomycin, MES buffer, FCCP and the substitution of helium for the O2/CO2 supply at
the indicated times. The coalescence of the cytosolic and mitochondrial Pi resonances after the cells were de-energised
by the addition of FCCP and the use of helium is also indicated (Closed Square). As excerpted from Cohen et al., (1978).
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Secondly, a titration curve of the mitochondrial pH measured by

31P

MRS has been

established in isolated mitochondria (8). The derived pK2 for mitochondrial Pi was ~6.7-6.8 (16),
a value in accordance with those observed in physiological cell suspension medium using standard
biochemical techniques (7). Lastly, Durand et al. (1998) in perfused liver, and Garlick et al., (1983)
in perfused hearts, demonstrated that the chemical shift of this second phosphate peak remained
unaltered when the cytosolic pH was manipulated through the addition of bicarbonate and CO 2 to
a perfusate. The Pialk resonance shifted rightward, allowing for better discrimination of the
mitochondrial phosphate resonance, and ruling out the possibility that this second peak originates
from the extracellular space in their preparation (10, 71). Collectively, these findings provide a
first set of evidence supporting the ability to detect a Pi pool of mitochondrial origin using 31PMRS.
2.4.3

MRS cell metabolism: The origin of the second peak of phosphate
A direct consequence of the

31P-MRS

studies on intracellular ∆pH was the in vivo

observation of a splitting of the Pi spectral region. An experimental approach used to identify the
origin of this second phosphate pool relies on modulating mitochondrial volume by changing the
experimental temperature condition. Specifically, electron micrographs of rat liver perfused at
37˚C and 4˚C demonstrated marked mitochondrial swelling at low temperatures (14). The osmotic
challenge induced by this increase in mitochondrial volume leads to a net influx of phosphate from
the cytosol to the matrix to maintain the transmembrane ion gradient. Using this approach, a second
Pi resonance could be detected in the perfused liver samples incubated at 4˚C and 15˚C, which was
absent at higher physiological temperatures (>25˚C; see Figure 12). Detection of a second Pi
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resonance in the range of 4-15 ˚C was subsequently confirmed in perfused heart(72), liver(15),
and isolated liver cells (65).

Figure 12. Typical 31P NMR spectra recorded during the thermic transition period from 37 to 4 ˚C.
Spectra (240 scans) were applied a line broadening of 5 Hz before Fourier transformation. Resonances b 1
and b2 were assigned to mitochondrial and cytosolic phosphate, respectively. As excerpted from Dufour et
al., 1996.

Incubation or perfusion with a medium containing valinomycin is another experimental
approach that has been implemented to discriminate the two phosphate peaks in isolated cell
preparations and tissues (see Figure 11.). Specifically, valinomycin is a mitochondrial-specific
potassium (K+) ionophore that amplifies the pH gradient across the mitochondrial membrane (73),
and thus, the chemical shift difference between cytosolic and matrix Pi resonances. In addition,
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this process is associated with a Pi influx in the mitochondria (74) and corresponding mitochondrial
swelling(65). Using this method, a second phosphate peak was consistently detected in liver cells
(7), perfused heart (10, 13), and isolated rat liver (65).
Lastly, in cell suspension, perchloric acid extraction (PCA) has routinely been shown to
collapse the second Pialk resonance, while the phosphate resonances of solution (in isolated
mitochondria) (8) or cytoplasm (in perfused cells and organs) were left unperturbed (10, 13). This
suggests the source of the Pialk resonance to be located in a region perturbed by the processes of
freeze-clamping and homogenization (10, 13). Although a contribution of exogenous solution Pi
on the spectral splitting of the phosphate resonance has been argued, its relatively small volume
(~20%) in the NMR cell, and the fact that pellets were suspended in phosphate-free suspension
medium, refutes this supposition (7). Collectively, these observations lend support to the
hypothesis that the alkaline Pi resonance is of mitochondrial origin.
2.4.4

MRS cell metabolism: Challenges to the measuring alkaline Pi in vivo
Three primary constituents dictate mitochondrial Pi “visibility” by

31P

MRS: (1) total

concentration of matrix Pi, (2) chemical shift, and (3) spectral line width (16). Since mitochondrial
Pi accumulates as a function of pH, and Pi is required for ATP synthesis, a significant proportion
of intracellular Pi is located in the mitochondrial matrix (11, 75, 76). The relatively slow exchange
rate of Pi (Vmax = 200 nmol/min•mg of mitochondrial protein) between matrix and cytosolic
compartments eliminates an effect of exchange broadening by Pi spectral peaks coalescing (at least
at high SNR) (77). Lastly, minimal, to no, effect of paramagnetic species and slow tumbling
macromolecules, as well as matrix hyperviscosity, on line broadening have been argued (16).
Nonetheless, some have questioned the ability of

31

P-MRS to detect inorganic phosphate

from the mitochondria. Paramagnetic ions, such as Ca2+ and Mg2+, are densely concentrated in the
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mitochondria and potentially lead to spectral line broadening (16). Indeed, at supraphysiological
Ca2+ concentrations (>5 nm/mg of mitochondrial protein), mitochondrial Pi is rendered invisible;
however, this has been attributed to precipitation, and not T1 or T2 contributions, which represent
the intrinsic longitudinal relaxation of the Pi net magnetization from which the MR signal is
acquired. However, within the physiological range of 0.1-0.2 µM in the mitochondria, the effect
of Ca2+ is trivial. This was also true for Mg2+; at high concentrations, T2 line broadening effects
rendered matrix Pi invisible, but was insignificant at physiological concentrations (0.1-0.5 nm)
(16). Therefore, under physiological concentrations of Ca2+ and Mg2+, paramagnetic line
broadening effects are unlikely to play a role in the invisibility of mitochondrial matrix Pi.
Indeed, the inability to detect the mitochondrial Pi signal in these earlier studies (9, 75, 78)
was likely due to T1 differential saturation effects. In perfused hearts, the T1 of cytosolic Pi under
fast pulsing conditions (9.4 T, wide-bore Bruker WM 360 spectrometer) was 1.0 ± 0.3 seconds
(10, 13). Under the same experimental condition, the T1 of the mitochondrial Pi resonance was
qualitatively estimated to be of the order of ~0.5 seconds at 9.4 T (10). This has been quantitatively
validated by progressive saturation and inversion-recovery experiments in isolated mitochondria
(T1 = 0.54 secs (16); T1 = 0.60 secs (8)) and perfused liver (T1 = 0.71 (14)) at 9.4 T.
The significance of relaxation parameters in MRS visibility was further demonstrated in
studies investigating temperature effects (14, 79). The rational for a ‘temperature-dependency’
was proposed on the fact that both longitudinal (T1) and transverse (T2) relaxation times are
regulated by molecular correlation times, which vary as a function of temperature. Using an elegant
experimental design, Dufour and colleagues quantified T1 and T2 relaxation times at low (4°C and
16°C) and high (25°C and 37°C) temperatures in perfused rat livers. Hypothermia (i.e., 4°C)
induced a considerable line sharpening of the inorganic phosphate resonance, which allowed for
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discrimination of the doublet Pi peak centered at 2.67 and 2.49 ppm. Importantly, the alkaline
resonance contribution was absent at 37°C. The T1 value of the main (cytosol) and secondary
(mitochondria) peak at hypothermia were 1.14 ± 0.24 and 0.71 ± 0.18 seconds, respectively (Table
3). At higher temperatures, only the cytosolic T1 could be derived, due to coalescence of the
phosphate peaks. Furthermore, the ability to resolve the mitochondrial Pi resonance, at low
temperatures (4°C), was well explained by the hypothermia-induced mitochondrial swelling by
influx of Pi (10, 14).
Table 2. T1 Values of Some Phosphorylated Metabolites of the Excised Rat Liver, Perfused under Various Conditions of
Temperature. T1 values are in seconds. As excerpted from Dufour et al., 1996.

2.4.5

MRS cell metabolism: Reproducibility in detecting alkaline Pi at 3T
Collectively, there is a wealth of evidence suggesting that the mitochondrial Pi signal can

be detected in vivo by 31P-MRS provided that optimal acquisition parameters, robust processing,
and spectral quantification are applied. At ultra-high magnetic fields (7 Tesla), the Pialk resonance
is discernable in resting human skeletal muscle, and further reveals a relationship with a dynamic
marker of mitochondrial function, such as PCr recovery (1, 2). Nonetheless, the short longitudinal
relaxation time (T1 < 1.5s) (3, 8, 14, 16) low concentration in resting human skeletal muscle (<1
mM), and close resonance proximity with the predominant cytosolic Pi peak (~0.4 ppm) present a
significant challenge to detect Pialk at lower field (≤ 3 Tesla) strengths. Although a lower field
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strength inherently reduces SNR, spectral resolution, and therefore, the power to detect Pialk, there
is merit in such application as a significant proportion of clinical magnets operate at 3T.
The goal of this project was to quantify the reproducibility of Pialk measured at 3T by a surface
coil in the skeletal muscle using a

31P-MRS

technique. Specifically, we quantified the within-

subject reproducibility of [Pialk] with a surface coil on the quadriceps using 31P-MRS by calculating
both the relative and absolute reproducibility of [Pialk] in sedentary to moderately active young
adults. We also determined the contribution from changes in coil location, shimming procedure,
and spectral processing by an automated software to the measurement variability of [Pialk].
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CHAPTER III
METHODS
3.1 Participants Characteristics
Following informed consent, 13 healthy, sedentary to moderately active, young adults (7 males
and 6 females) were recruited for this study. Participants were sedentary to moderately active, i.e.
not participating in structured physical activity more than 3 times a week (documented after
recruitment by both questionnaire and accelerometry), non-smokers, free from diabetes, and any
known cardiovascular, peripheral vascular, neuromuscular, or pulmonary diseases. Uniaxial
accelerometry (GT3X, Actigraph, Pensacola, FL) was used to characterize habitual physical
activity levels. Briefly, participants were instrumented with an accelerometer during the screening
and instructed to wear the accelerometer for seven days on their non-dominant hand. The study
was approved by the Human Research Protection program at the University of Massachusetts
Amherst. All experimental trials were performed in a thermoneutral environment, at the same time
of day, with the subjects fasted overnight and no strenuous exercise for the past 24 hrs.
3.2 Experimental Design
Assessment of within subject reproducibility: Participants reported to the lab on two separate visits
spanning a 7-day period (4±2 days). Subjects laid supine within the bore of a 3T MR scanner
(Skyra, Siemens Medical Solution, Erlangen, Germany) to measure resting concentration in
phosphorylated compounds and intracellular pH.
Assessment of potential sources of measurements variability:
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Protocol 1 “effect of coil position”: In one subject, the coil was moved along the quadriceps and
resting metabolites were measured in 6 different locations separated by 4 cm in the distal-toproximal direction (Figure 25.).
Protocol 2 “effect of shimming”: To quantify the measurement variability from repeated shims,
10 consecutive scans were conducted on the quadriceps of the same participant with the shimming
procedure reset for each scan. This test was conducted in the morning after an overnight fast. The
participant remained supine on the bed of the magnet at all times for assessments of coil position
and shimming procedure.
Protocol 3 “effect of spectral processing and quantification”: One spectrum randomly selected in
the dataset was analyzed 20 times using a time-domain fitting routine (80) and the AMARES
algorithm (81) incorporated into the CSIAPO software (82) and with the same prior knowledge
for the metabolites of interest.
3.2.1

Phosphorus Magnetic Resonance Spectroscopy (31P-MRS)
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Figure 13. Average and individual full width and half max (FWHM) values for PCr (left) and water (right) for visit 1 and 2.

A custom-built 31P/1H surface circular coil (80 mm single-loop 31P coil surrounded by a 100 mm
1H

coil loop) with linear polarization was positioned above the right quadriceps muscle and tightly

secured to minimize any displacement. Three-plane scout proton MR images with automatic
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localized map shimming were initially acquired to determine the position of the leg with respect
to the surface coil. Once visual confirmation of the coil was obtained, a manual localized map
shimming procedure was performed to reach full width at half maximum (FWHM) of at most 45
Hz for water (1H; Visit 1: 37.3 ± 5.4 and Visit 2: 37.2 ± 2.8 Hz) and 12 Hz for PCr (31P; Visit 1:
11.8 ± 0.8 and Visit 2: 11.6 ± 0.6 Hz) (Figure 13). Then, a single 31P MR spectrum was obtained
with the following parameters: TR=1500 ms, Bandwidth=4000 Hz, 2048 data points, Nominal Flip
Angle=80, 200 Averages, 1H decoupling WALTZ-4 at 50% i.e., 240 ms, hard pulse 100 s.
Longitudinal Relaxation (T1) & Repetition Time (TR)
Radio frequency (RF; designated as the B1 field) pulses perturb the net magnetization (M)
of 31P nuclei, from which the MRS signal is acquired (Figure 14.). Under fully relaxed conditions,
M is parallel to the main magnetic field (Bo) in a state of thermal equilibrium. Finely tuned RF
pulses tip the longitudinal component of M (i.e., M z) into the transverse plane, and the rate by
which Mz regrows back to its initial maximum value (Mo) is termed longitudinal relaxation (i.e.,
T1 relaxation). This is an important MRS parameter, as differences in T1 relaxation times between
phosphorus metabolites (e.g., ATP and Pi), and in the present study, chemical environments (i.e.,
cytoplasm vs. matrix), dictate spectral resolution of higher order multiplets.

Figure 14. Longitudinal (T1) relaxation time. B0; main magnetic field, M0; net magnetization, Mz; transverse magnetization, B1;
radio frequency (RF) pulse/magnetic field. Images generated on biorender.
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T1 relaxation times are conventionally measured using progressive saturation or inverserecovery techniques. Initial studies on the mitochondrial origin of Pialk were able to quantify the
T1 of the cytosolic Pi peak (7, 8), but due to inherent technical limitations, could only qualitatively
characterize the T1 of the mitochondrial peak (10, 13). Under fast repetition rates (i.e., repetition
times [TR]), the behavior of Pialk assumed a T1 of half the magnitude of the cytosolic T1,
quantitatively validated in subsequent studies (3, 11, 16). Indeed, matrix metabolites exhibit
markedly reduced T1 relaxation(14) (Table 3.) visible only under fast pulsing conditions (i.e.,
lower TR).
Accordingly, taking into account the T1 characteristics of both phosphate peaks, the present
study initially sought to optimized TR at 3T. A first set (n=3) of

31P

progressive saturation

experiments was performed (TR=550-2500ms) using an FID (free-induction-decay) pulse
sequence with a 100µs hard pulse and the following parameters (receiver bandwidth = 4 kHz, 2048
data points, nominal flip angle=70°, 120 averages per spectrum, 1H decoupling WALTZ-4 at 50%,
i.e., 240 ms). Due to the very short T1 and specific absorption rate (SAR) limit due to decoupling,
a second set (n=2) of

31P

progressive saturation experiments was performed (TR=300-1500ms)

without 1H decoupling using the following parameters (receiver bandwidth=4 kHz, 2048 data
points, nominal flip angle=70°, 120 averages per spectrum) and transmitter frequency set to 1.5
ppm upfield from the PCr peak. Data from these experiments are presented in Figure 15. The
apparent T1 of Pialk was 412 ± 112 ms.
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Figure 15. Progressive saturation experiments at TR ranging from 550-2500ms using an FID (free-induction-decay) pulse sequence
with a 100µs hard pulse and the following parameters (receiver bandwidth: 4 kHz, 2048 data points, nominal flip angle: 70°, 120
averages per spectrum, 1H decoupling WALTZ-4 at 50%, i.e., 240 ms). A. Signal intensity and B. Signal to noise ratio (SNR )at
different repetition times. n = 5.

Nominal Flip Angle
T1 relaxation is dictated, among other factors, by the magnitude of the rotational
displacement experienced by M following the application of an RF pulse; known as flip angle
(Figure 15A.). Given an RF pulse with a flip angle of ɑ, the transverse component of M (i.e., Mx,y)
is given by the equation Mosin(ɑ), and the longitudinal component (i.e., Mz) by the equation
Mocos(ɑ). Since the MR signal is largely a function of M x,y, one can see that stronger signals are
produced at larger flip angles, i.e., given ɑ = 90°, all of Mz is converted to Mx,y with a maximum
value of Mo.
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Nonetheless, when optimizing the flip angle, it is imperative to account for MR sequences
with repetitive RF pulses, where TR influences both T1 relaxation and MR signal strength. If TR
is sufficiently long, on the order of > 4-5x the T1, then Mz will adequately recover to Mo.
Accordingly, under these conditions, a 90° flip angle would generate the most significant signal.
However, in the present study, a series of repetitive RF pulses at short TR (to account for the short
T1 relaxation of Pialk) would preclude the application of 90° flip angles. The rational is based on
insufficient relaxation of Mz to Mo, establishing a new steady-state longitudinal magnetization
(Mss) on the order of M ss < Mo, an NMR phenomenon known as partial saturation.

Figure 16. Effect of flip angle on signal intensity in the skeletal muscle at 3T (receiver bandwidth: 4 kHz, 2048 data points,120
averages per spectrum, 1H decoupling WALTZ-4 at 50%, i.e., 240 ms). A. Framework of the flip angle (images generated in
biorender). B. Signal intensity at flip angles of 50-90° in the present study. n = 5.

A series of partial flip angles (<90°), thus, would create an appreciable transverse
magnetization while largely preserving the longitudinal magnetization. The Mss would be
minimized, as would signal loss from the partial saturation effects. The strength of the MR signal,
therefore, is a fine balance between optimal flip angles and sufficient transverse magnetization. To
maximize the MR signal in the present study, while minimizing partial saturation effects, nominal

47

flip angle was optimized in accordance with the fast-pulsing conditions necessary to discriminate
the small mitochondrial inorganic phosphate peak (see Figure 16B.).
Proton (H+) Decoupling and pulse duration
A common phenomenon in

31P-MR

spectroscopy is the splitting of spectral peaks into

higher order multiplets. Formally known as j-coupling, spectral line-splitting is the result of
electron-mediated interactions between two neighboring nuclear spins residing within the same
molecule. This is the case for the current phosphate doublet, which is a unique type of
heteronuclear j-coupling between chemically distinct 31P and 1H nuclei. Contraire to homonuclear
j-coupling (between adjacent 31P nuclei, e.g., ATP), where the coupling constant (spacing between
sub peaks in a multiplet) is large and allows for discrete line separation, heteronuclear j-coupling
is subtle, and often results in a broadening of spectral lines. Specifically, Pialk has a spectral peak
separation of 0.4 ppm, or ~20 Hz at 3T, with the adjacent larger Pi peak.

Figure 17. Progressive saturation experiments at TR ranging from 550-2500ms using an FID (free-induction-decay) pulse sequence
with a 100µs hard pulse and the following parameters (receiver bandwidth: 4 kHz, 2048 data points, nominal flip angle: 70°, 120
averages per spectrum, 1H decoupling WALTZ-4 at 50%, i.e., 240 ms). A. Signal intensity at varying decoupling durations. B.
Signal intensity at different pulse durations. n = 3.

Consequently, the technique of proton decoupling has been widely implemented to
improve spectral resolution of heteronuclear-coupled phosphorus signals. Briefly, application of
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finely tuned RF-irradiation at the 1H Larmor Frequency uncouples the 1H nuclei reference state
from the 31P cohort. The effect is instantaneous and useful at ≤ 3T where line widths are in the
order of the j constants (< 7 Hz). Current proton decoupling techniques are broadband, which
incorporate a series of short composite pulses phase-cycled to disrupt the 1H resonance.
Accordingly, the present study implemented a wideband alternating-phase low-power technique
for zero-residual-splitting (WALTZ-4) at 50% i.e., 240 ms, hard pulse=100 s, which has been
optimized for limited specific absorption rate (SAR) and use in conjunction with surface-coils
(Figure 17.).
Surface Coils
As cited in a previous section, the first applications of 31P MR spectroscopy were in isolated
cells, tissues, and much later, perfused organs, i.e., in vitro. Translation to in vivo human skeletal
muscle was initially not feasible given technological constraints of early MRS; namely, limited
bore size83 and spatial discrimination84. Although the advent of large-bore superconducting
systems facilitated studies in the intact human, the large volume of skeletal muscle (relative to
tissues) presented issues of heterogeneity, not suitable for spectroscopy. Consequently, the
development of surface coil to spatially localized

31

P-MRS was a major advance in the field for

the study of skeletal muscle metabolism (84).
Standard surface coils are positioned in close contact to the muscle of interest to detect
phosphorus signals from the tissue underneath (84). Often in the shape of small circle, the design
of these coils allows for the quantification of data in a known volume of interest without
contamination from neighboring tissue. The signal sensitivity of standard surface coils is roughly
proportional to the coil’s diameter, and therefore, provides high spatial and signal sensitivity to
surface tissue as illustrated in Figure 1885. Importantly, this feature avoids contamination from
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deeper structures and allows for spatially selective measurement of metabolites. Accordingly, the
high signal sensitivity and spatial signal localization offered by surface coils were well suited for
our study design, and 31P-MRS data were acquired with a dual tuned 31P-proton (1H) custom-made
surface coil with linear polarization positioned above the quadriceps (largely superficial muscles
that includes the rectus femoris). The

31P

single-loop coil diameter was 80 mm which was

surrounded by the 100 mm 1H coil loop (Stark Contrast, Germany) thus allowing for a signal
localization

depth

of

approximately

~4

cm

in

the

muscle.

Figure 18. Illustration of surface coil signal sensitivity. Measured B1 amplitude in the median sagittal slice with a surface
coil. Black dashed boxes denote the position of the phantom. Relative positions are in cm. The greater B1 magnitude indicates
greater signal from the region close to the coil. From Dubois et al., 2019.
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Spectral processing

Figure 19. Representative spectrum acquired at repetition time [TR]: 1500 ms, Bandwidth (BW): 4000 Hz, 2048 data points,
Nominal Flip Angle (FA): 80°, 200 Averages, 1H decoupling WALTZ-4 at 50% i.e., 240 ms, hard pulse 100 µs. A. Spectrum not
corrected for zero order PHASE adjustment. B. Spectrum corrected for zero order PHASE adjustment only. For Panel A., peak at
20 ppm is a phantom. Highlighted in Panel B. is the Pi peak with the alkaline peak upfield.

To assess measurement reproducibility of Pialk in the quadriceps muscle, we quantified
measurement variability due to spectral processing by automated software (CSIAPO) (86). Raw
data (FID before Fast Fourier Transformation [FFT], Figure 20.) were imported into CSIAPO and
the spectra auto-populated. The first step in spectral processing was to establish an even baseline
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for the PCr peak, which was accomplished by adjusting the Zero Order Time PHASE using both
‘gross’ and ‘fine’ adjustment parameters (Figure 19.).

Figure 20. Representative raw Free Induction Decay (FID) signal before a Fast Fourier Transformation (FFT).
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C.

Figure 21. Representative spectrum acquired at repetition time [TR]: 1500 ms, Bandwidth (BW): 4000 Hz, 2048 data points,
Nominal Flip Angle (FA): 80°, 200 Averages, 1H decoupling WALTZ-4 at 50% i.e., 240 ms, hard pulse 100 µs. A. Spectrum not
corrected for first order PHASE adjustment. B. Spectrum corrected for first order PHASE adjustment. C. Spectrum with PCr
referenced at 0 ppm per convention. However, for all spectral analysis, PCr was referenced at -2.45 ppm.
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Secondly, a First Order Time PHASE adjustment of the ß-ATP peak was performed. The goal
with the First Order Phase adjustment is to align the ß-ATP peak with the 0 baseline, making
sure to not compromise the Pi peak (Figure 21.).
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Figure 22. Representative spectrum acquired at repetition time [TR]: 1500 ms, Bandwidth (BW): 4000 Hz, 2048 data points,
Nominal Flip Angle (FA): 80°, 200 Averages, 1H decoupling WALTZ-4 at 50% i.e., 240 ms, hard pulse 100 µs. A. The green line
represents the estimate fitting of the sequence. Note the marked splitting of the inorganic phosphate peak (second peak to the left
of the PCr peak), evidence that our fitting parameter could detect both Pi peaks. B. Residuals associated with the fitting procedure
in yellow lines.

After phase correction, the spectral frequency is adjusted using PCr as the reference (-2.45
ppm) to account for potential variation in carrier frequency. Lastly, to improve spectral quality and
splitting of the Pialk resonance from the main resonance Pi, a 2Hz Gaussian filter was applied on
all spectra based on preliminary work.
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The spectra were then fitted using AMARES and a priori information of the metabolites
of interest (PME, Pialk, Picyt, PDE, PCr, ATP-α,γ,β (Figure 22.). 12 Lorentzian resonances were
defined as a priori information to AMARES. The fitting constraints were frequency range, fixed
phase, amplitude, decay
Statistics
Test-retest absolute and relative reproducibility were analyzed using within-subject
coefficient of variation (CV) and intra-class correlation coefficients (ICC), respectively, as
described previously (87). Relative reproducibility is related to an individual maintaining his/her
position, e.g., rank, within a sample with repeated measurements (88). We assessed this type of
reproducibility with the ICC, a two-way random effects model with single measurement
reproducibility in which variance over the repeated sessions is considered. The ICC indicates the
error in measurements as a proportion of the total variance in scores. According to Atkinson &
Nevill (1998), the following criteria are recommended to qualitatively characterize relative
reproducibility as assessed by the ICC: ICC = 0.7-0.8 as ‘questionable’, ICC = 0.8-0.9 as ‘good’,
and an ICC > 0.9 as ‘high’ (88). Nevertheless, like the Pearson’s r, an ICC close to 1 indicates
‘excellent’ reproducibility.
Absolute reproducibility is the degree to which repeated measurements vary for individuals
and the measurement system88. This was performed by calculating the within subject CV (i.e.,
test-retest) and measurement procedure (i.e., coil positioning, repeated shims, automated spectral
processing), and then reporting the mean CV for the respective dependent variables. Accordingly,
the within subject CV was calculated as the SD of the measurements recorded during both visits,
or for each scan, and then divided by the mean of the two visits as previously described (87). This
assessment of CV is different from the intersubject that quantifies the variability within the group
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rather than the variability within subjects that requires a repeated measurement design. A CV of ≤
10% was deemed ‘excellent’ (88). The corresponding result was expressed as a percentage. ICC
and CV analysis were done using a downloadable spreadsheet (87). Results are presented as means
± SD in tables, and expressed as median and range (Table 3).
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CHAPTER IV
RESULTS
4.1 Participants
Baseline subject characteristics (males = 7; females = 6), including anthropometric, physical
activity level, and blood profile are documented in Table 3.
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Table 3. Subject characteristics
Total (N=13)*

Total (N=13)#

Males (n=7)

Females (n=6)

p-value

22 ± 3

22; 18-29

22 ± 4

22 ± 3

0.63

Height (cm)

172.9 ± 9.7

170.5; 163-192

178.6 ± 8.7

164.8 ± 2.1

0.01

Mass (kg)

70.5 ± 12.8

68.3; 51.1-91.3

76.2 ± 12.5

62.4 ± 8.6

0.05

BMI (kg/m2)

23.6 ± 3.6

23.3; 17.51-29.14

24.0 ± 4.1

23.0 ± 3.2

0.64

MVPA (min/day)

175 ± 180

119; 52.38-218

211 ± 242

134 ± 59

0.47

Step Counts

7812 ± 2432

7060; 3764-13,812

7192 ± 903

8535 ± 3472

0.34

Hemoglobin (g/dl)

14.26 ± 1.78

14.7; 12.3-17.3

15.80 ± 1.19

13.02 ± 0.97

0.01

Hematocrit (%)

42 ± 5

42; 37-50

46 ± 3

38 ± 2

0.81

Glucose (mg/dl)

87.27 ± 3.69

88; 80-93

85.00 ± 3.46

89.17 ± 2.86

0.06

Cholesterol (mg/dl)

176.40 ± 33.78

182.5; 116-225

160.00 ± 18.87

187.33 ± 38.50

0.23

HDL (mg/dl)

59.20 ± 15.13

54; 42-86

48.75 ± 6.40

66.17 ± 15.56

0.07

LDL (mg/dl)

102.60 ± 22.73

112; 55-125

95.75 ± 17.29

107.17 ± 26.23

0.47

Triglycerides (mg/dl)

72.30 ± 18.52

75; 40-95

76.75 ± 16.46

69.33 ± 20.70

0.57

Age (yrs.)

*Values

are expressed as mean ± SD
are expressed as median; range
BMI: Body Mass Index; MVPA: Moderate-Vigorous Physical Activity; HDL: High Density Lipoproteins; LDL: Low Density
Lipoproteins
#Values
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4.2

Test-Retest Reproducibility of Pialk and Phosphate Metabolites
Pialk (CV=10.6 ± 5.4%) and Pialk/Picyt (CV=10.3 ± 8.1%) demonstrated an absolute

reproducibility close to the 10% cut-off deemed appropriate for excellent reproducibility. Relative
reproducibility, as assessed by the ICC, was ‘very good’ (ICC=0.80 [0.80,0.804]) and ‘good’
(ICC=0.71 [0.71,0.708]) for Pialk and Pialk/Picyt, respectively (Table 4.; Figure 23., 24.).
Accordingly, individual data for both Pialk and Pialk/Picyt were close to the line of identity, i.e., a
reference line (y=x) comparing two separate data sets expected to be identical, and with a
homogeneous distribution around the line further confirming the high reproducibility of the
quantification of these metabolites (Figure 23., 24.).
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Table 4. Within-subject reproducibility in 31P-MRS variables at rest
Resting Metabolite

Visit 1

Visit 2

Mean CV (%)

ICC (95% CI)

PCr (mM)

37.2 ± 3.1

36.9 ± 3.1

3.3 ± 2.2

0.77 (0.77,0.768)

Pi (mM)

3.6 ± 0.7

3.5 ± 0.6

5.9 ± 4.4

0.84 (0.84,0.837)

Pialk (mM)

0.35 ± 0.09

0.35 ± 0.10

10.6 ± 5.4

0.80 (0.80,0.804)

PDE (mM)

1.80 ± 0.42

1.68 ± 0.42

5.7 ± 5.7

0.94 (0.94,0.936)

Total NAD (mM)

1.11 ± 0.23

1.31 ± 0.32

14.4 ± 0.2

0.23 (0.23,0.231)

Pialk/Picyt

0.10 ± 0.03

0.10 ± 0.03

10.3 ± 8.1

0.71 (0.71,0.708)

β-ATP (a.u.)

65431 ± 14522

60322 ± 20330

11.4 ± 29.6

0.41 (0.41,0.409)

pH Cytosolic

6.97 ± 0.02

6.97 ± 0.02

0.1 ± 0.1

0.64 (0.64,0.640)

pH Mitochondrial

7.46 ± 0.03

7.44 ± 0.03

0.2 ± 0.1

0.74 (0.74,0.745)

*Values are expressed as mean ± SD
CV = coefficient of variation, CI = 95% lower and upper confidence intervals
Total NAD includes NAD+NADH
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PDE exhibited ‘excellent’ absolute (CV: 5.7 ± 5.7%), and ‘very good’ relative (0.94
[0.94,0.936]), reproducibility (Table 4, Figure 23.). However, a systematic bias between visit 1
(1.80 ± 0.42 mM) and 2 (1.68 ± 0.42 mM) was detected as illustrated by the large proportion of
[PDE] values below the line of identity (Figure 23.). Total NAD (NADH+NAD) demonstrated an
absolute reproducibility (CV=14.4%) lower than Pialk and PDE, with also “poor” relative
(ICC=0.23) reproducibility (Table 4 and Figure 25.).
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Figure 23. Top three panels represent the means and individual data for Pialk, PDE, and PCr. Scatter plot of Pialk, PDE, and PCr
comparing visit 1 and visit 2. Dashed line represents the ‘line of identity’.
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Figure 24. Mean and individual data for the ratio of Pialkaline and Picytosolic (left). Scatter plot of the ratio of Pialkaline and Picytosolic
comparing visit 1 and visit 2. Dashed line represents the 'line of identity'.

Phosphate metabolites with a greater resolution and signal intensity than Pialk and PDE,
PCr (CV = 3.3 ± 2.2%; ICC=0.77 [0.77,0.768]) and Pi (CV = 5.9 ± 4.4; ICC=0.84 [0.84,0.837]),
demonstrated ‘excellent’ and ‘moderate’ to ‘very good’ absolute and relative reproducibility
respectively (Table 4; Figure 23., 25.)
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Lastly, both the ‘acidic’ cytosolic pH (CV: 0.1 ± 0.1%) and alkaline ‘mitochondrial’ pH
(CV: 0.2 ± 0.1%) demonstrated the highest absolute reproducibility of all measurements acquired
(Table 4 and Figure 25.). However, their relative reproducibility was ‘poor’ (ICC < 0.7).
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Figure 25. Means and individual data for inorganic phosphate (Pi), total nicotinamide adenine dinucleotide (NAD+NADH), and
cytosolic and mitochondrial pH
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4.3

Effect of coil location on Pialk quantification

The between-sites coefficient of variation for Pialk was 21.1% (Table 5, Figure 26.). When sites 1
and 2 were excluded from the analysis, the CV for Pi alk between sites decreased to 7.9%. The other
phosphate metabolites (PCr, Pi, β-ATP and PDE) exhibited a similar pattern with higher
concentrations at sites 1 and 2 (Table 5.) The total phosphate signal was not different along the
length of the thigh (Table 5). However, the full width half maximum of PCr was substantially
higher at site 1 and 2 (Table 5).

Figure 26. Pialk concentrations across the six different sites (left). The six different ‘sample volumes’ were measured along the
longitudinal length of the quadriceps, in 4 cm intervals, starting at the patella and with the muscle fully relaxed (right). FWHM:
Full Width Half Maximum of PCr.

65

Table 5. Measurement Variability in Pialk and Phosphate Metabolite Quantification due to Coil Placement
Pialk (mM)

PDE (mM)

Pi (mM)

PCr (mM)

β -ATP

Sum

Site 1

0.55

2.46

3.4

31.9

76900

368810

Site 2

0.46

2.37

3.3

32.0

84000

399570

Site 3

0.33

2.14

2.8

29.5

89500

388360

Site 4

0.38

2.10

2.9

29.0

89200

383880

Site 5

0.38

2.16

3.0

30.5

79300

357510

Site 6

0.33

2.00

2.9

28.9

78300

333970

21.06 %

7.93 %

8.1 %

4.6 %

6.7 %

6.4 %

Sample Location

Coefficient of Variation (%)
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4.4

Effect of repeated shimming on Pialk Quantification

Pialk demonstrated ‘excellent’ absolute reproducibility (CV: 6.6 %) (Table 6.). Likewise, and as
expected, PCr (CV: 1.5%), Pi (CV: 3.0%), and PDE (CV: 1.7%) all demonstrated ‘excellent’
absolute reproducibility.
4.5

Effect of spectral processing on Pialk and phosphate metabolites reproducibility

Pialk demonstrated excellent absolute reproducibility (CV: 2.3 %) (Table 6.). Likewise, PCr (CV:
0.7%), Pi (CV: 0.7%), and PDE (CV: 0.9%) all demonstrated ‘excellent’ absolute reproducibility.
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Table 6. Reproducibility related to coil positioning, within-session repeated shims, and spectral processing
PCr (mM)

Pi (mM)

Pialk (mM)

PDE (mM)

pH Cyto

pH Mito

0.40 ± 0.09
(21.1)

2.21 ± 0.18
(7.9)

7.01 ± 0.01
(0.1)

7.49 ± 0.04
(0.5)

2.19 ± 0.04
(1.7)

6.99 ± 0.00
(0.1)

7.44 ± 0.02
(0.3)

1.19 ± 0.01
(0.9)

6.98 ± 0.00
(0.0)

7.43 ± 0.00
(0.0)

a. Effect of coil positioning (n=6 measurements)
Metabolic variable
(% CV)

30.3 ± 1.4
(4.6)

3.1 ± 0.2
(8.1)

b. Within-session reproducibility (n=10 measurements)
Metabolic variable
(% CV)

29.1 ± 0.4
(1.5)

3.0 ± 0.1
(3.0)

0.40 ± 0.03
(6.6)

c. Reproducibility of spectral processing (n=20 measurements)
Metabolic variable
(% CV)

32.2 ± 0.2
(0.7)

2.7 ± 0.0
(0.7)

0.37 ± 0.01
(2.3)

Values are expressed as mean ± SD, with the coefficients of variation (CV) in parentheses.
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CHAPTER V
DISCUSSION
The aim of the present study was twofold: (1) to quantify the test-retest absolute and relative
reproducibility of

31P-MRS-derived

Pialk at 3T in resting quadriceps muscle of healthy young

adults; and (2) to determine the contribution to [Pialk] measurement variability from coil placement
and repeated shims within the same session, as well as spectral processing using an automated
software procedure86. Although greater than the 10% cut-off for ‘excellent’ absolute
reproducibility, a test-retest CV of 10.6% is still consistent with our hypothesis of acceptable
reproducibility. Importantly, ‘excellent’ reproducibility from within-session repeated shims and
spectral processing was reported for Pialk in the present study. Test-retest variability of Pialk was
two-fold greater than other well-resolved metabolites in the

31P

spectrum, such as PCr, Pi, and

PDE. Coil location affected Pialk quantification, with higher [Pialk] in the distal region of the thigh
33% of femur length) caused by magnetic field inhomogeneity in the sampled area. Consecutive
scans within the same day with repeat of the shimming procedure resulted in smaller Pialk
variability (CV=6.6%) than within-subject reproducibility during a 3-7 day period (CV=10.6%).
Finally, the automated spectral processing procedure was highly reproducible even for Pialk (CV ≤
2.3%). Collectively, the present study supports the reproducibility of Pialk quantification by 31P
MRS using a surface coil on the quadriceps at 3T, provided as long magnetic field homogeneity is
sufficient (FWHM of PCr < 12.5 Hz).
5.1 Test-retest absolute reproducibility of high-energy phosphate metabolites by 31P-MRS
Consistent with our initial hypothesis, a central finding of the present study was the
documentation of an acceptable absolute reproducibility (CV = 10.6 ± 5.4%; marginally greater
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than the 10% cut off for ‘excellent’ reproducibility) and “good” relative reproducibility (defined
as an ICC ranging from 0.80-0.90) for [Pialk]. Likewise, PCr, Pi, PDE, and ATP- β demonstrated
“excellent” absolute and ‘good’ to ‘high’ relative reproducibility (Table 4.). In the present study,
[Pialk] was ~0.35 mM in the quadriceps of healthy young adults, which was two-fold higher than
values reported in the quadriceps of obese individuals (~0.18 mM) (2), but within the range of
values measured in untrained young adults at 7T (~0.28-0.42 mM)2,90. In contrast, Sedivy et al.,
(2020), reported substantially higher [Pialk] in the plantar flexor muscles of healthy older
individuals (~0.8 mM) and patients with peripheral arterial disease (~3.0 mM) a 3T (91). The
reason for this discrepancy is unclear but might originate from the different muscle investigated
(quadriceps vs. plantar flexors), the age of the subjects (young vs. older adults), and the different
TR used (1.5 s vs. 15 s in the study by Sedivy et al., 2020) which might result in greater overlap
with the cytosolic Pi signal.
It is noteworthy that despite the large differences in concentration between Pialk and the other
metabolites (e.g., PCr was ~80 fold higher, Pi ~7 fold higher than Pi, and PDE ~4 fold higher than
Pialk) the metrics of absolute and relative reproducibility were high, and importantly, within a close
range from these well-resolved metabolites, thus supporting our hypothesis that Pialk can be
robustly and reproducibly quantified. To put this in perspective with a well-characterized
metabolite, studies conducted at 1.5T reported CVs for cytosolic Pi of 27% from consecutive
measurements in the tibialis anterior muscle (TA) (92) and 14% when measured 2 months apart in
the quadriceps (93). Other studies performed at 3T also reported CVs for cytosolic Pi of 15% in
the tibialis anterior muscle with a 10-day test-retest design (94) and 8% in the plantar flexor
muscles with a one-week test-retest design (95). Only two studies calculated the ICC of

31P

metabolites and reported ICC values of 0.79 for cytosolic Pi in the plantar flexor muscles with
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measurements performed 1 week apart (95) and an ICC of 0.14 for the cytosolic Pi in the
quadriceps with measurements performed 2 months apart (93).
Collectively, these findings suggest that Pialk can be reliably quantified in the quadriceps at 3T,
with a reproducibility similar to other well-studied phosphate metabolites (PCr, Pi, PDE).
Furthermore, a high ICC for Pialk confirm that the acquisition technique and processing tools
employed here enable to reliably detect, with a high level of sensitivity, fine changes in this lowersignal metabolites in the skeletal muscle at 3T. Such finding is crucial for the longitudinal
assessment of Pialk in the context of interventional studies and the long-term prospect of using this
metabolite as a biomarker of mitochondrial content.
5.2 Technical consideration for the measurement of Pialk
Several aspects need to be considered to optimize the spectral resolution and reproducibility
of Pialk. Indeed, Pialk quantification benefits from fast repetition rates (i.e., repetition times [TR])
due to its short T1 relaxation time relative to cytosolic Pi. Using a progressive saturation technique,
the apparent T1 of Pialk was 412 ± 112 ms in the present study at 3T. This short apparent T1 was
also consistent with a maximal signal intensity for a nominal flip angle of 80 degrees under fast
pulsing conditions (Figure 16). The value estimated in the present study is also in agreement with
the T1 of the alkaline Pi resonance measured in isolated mitochondria (T1 = 0.54 secs (16); T1 =
0.60 secs (8)) and perfused liver (T1 = 0.71 (14)) at ultra-high magnetic field (9.4 T); although
slightly longer apparent T1 (1.4 ± 0.5 s) have been reported in the skeletal muscle at 7T (3).
Previous studies in humans used longer TRs (4-5 s (3, 19) and 15 s (2,91,96)) resulting in greater
saturation of the cytosolic Pi, and thus greater overlap in the signal of the two Pi pools (Figure
15B). In addition, the faster pulsing conditions used in the present study allowed more signal
averaging to improve the SNR without leading to unreasonably long acquisition time (acquisition
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time ~5 min in the present study). Finally, the prolonged irradiation (250 ms, Figure 17) of the 1H
coupled to 31P using a decoupling pulse Waltz-4 available on most clinical MR scanners improved
the signal intensity and spectral resolution of the Pialk peak. Such enhancement in the signal has
previously been demonstrated to improve the repeatability of metabolite measurements (97).
Together, the optimization of these acquisition parameters contributed to the high reproducibility
of Pialk despite its low concentration and small chemical shift difference with Picyt.
5.2 Measurement Reproducibility of high energy phosphate metabolites
5.2.1

Effect of coil location in Pialk quantification
When the coil position was moved on the thigh in the distal to proximal direction, the

between-site CV for Pialk was 21.1% (Table 6), whereas PCr (CV: 4.6%) and Pi (CV: 8.1%) were
only marginally affected. Interestingly, when sites 1 and 2, which displayed higher concentration
of Pialk than other sites, were excluded from the analysis, the CV for Pialk decreased to 7.9%.
Conceptually, the greater Pialk in those distal sites can originate from different muscle fiber
properties in the sampled region (97) or change in coil loading/shimming quality.
A recent study by Horwath et al., (2021) reported no differences in fiber type along the
longitudinal orientation of the vastus lateralis using muscle biopsies thus ruling out any effect of
muscle fiber typology on the present findings. The effect of coil location on the PCr recovery time
constant, an index of mitochondrial function, is however more controversial with some studies
documenting shorter PCr recovery in the proximal region of the tibialis anterior (98,99), whereas
no difference was observed in the vastus lateralis (100).
Although the total phosphate content of the spectra did not vary across sites, the FWHM
of PCr, i.e., the homogeneity of the magnetic field in the sampled area, was higher at Sites 1 and
2 compared to other sites (Figure 25.). This larger linewidth may have resulted in an overlap with
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the cytosolic Pi signal and thus Pialk signal overestimation during spectral fitting. In contrast, other
well-resolved and higher-signal magnitude metabolites (PCr, PiCyt, ATP) would be less susceptible
to such a small decrease in shimming quality as indicated by their unchanged concentration.
The measurement variability from coil positioning in the present study underscores the
importance of coil placement for Pialk quantification. Accordingly, additional data will be collected
to provide further guidance on the location placement for adequate magnetic field homogeneity
along the length of the thigh when measuring Pialk in the quadriceps. Alternative strategies will be
to use localized sequences (e.g., ISIS, PRESS) for high homogeneity in the region of interest.
5.2.2

Effect of repeated shimming on Pialk quantification
In accordance with our initial hypothesis, 10 consecutive scans performed on the same

participant with the coil placed at mid-thigh resulted in ‘excellent’ absolute reproducibility for
Pialk (CV: 2.3 %, Table 6), which was of similar magnitude as the CVs for PCr (CV: 1.5%), Pi
(CV: 3.0%), PDE (CV: 1.7%), and pH (CV: 0.1-0.3%). These CVs, including Pialk, are actually
lower than values previously reported in the skeletal muscle by other 31P studies at lower magnetic
field (1.5T) (92,93). Besides differences in magnetic field, manual shimming was performed after
the automatic localized map shimming procedure to lower PCr FWHM below 15 Hz, which likely
contributed to better spectral resolution and more consistent quantification.
5.2.3

Effect of spectral processing and quantification on Pialk and phosphate metabolites
reproducibility

Using a time-domain fitting routine and the AMARES algorithm (81), with the same prior
knowledge for the metabolites of interest, incorporated into the CSIAPO software (82), the
quantification of all major phosphate metabolites was extremely reproducible (‘excellent’) with
CVs below 1%, reaching 2.3% for Pialk. These values are in line with Layec et al., (2009) and
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superior to the study by Miller et al. (1995), which relied on a manual curve fitting program thus
more prone to quantification error. Despite the low concentration and close spectral proximity with
the cytosolic Pi, the quantification of Pialk was highly reproducible in the present experimental
consideration, which confirm the robustness of the present automated processing by CSIAPO in
quantifying this 31P-MRS-derived metabolite.
5.3 Perspectives
Collectively, an ‘excellent absolute’, and for most markers, ‘good’ relative, reproducibility
suggests that these measurements are sensitive to both (1) changes over longitudinal periods and
(2) between-subjects. The present findings of high Pialk reproducibility in a sample of healthy
young adults supports the application of this technique in detecting Pialk in different populations
and across treatment/therapeutic interventions. Whether the quantification and reproducibility of
Pialk extends to different population groups, characterized by distinct clinical profiles, remains to
be investigated if Pialk is proven to be related to mitochondrial content. Reproducibly quantifying
Pialk at 3T in a clinical setting is thus promising and warrants future investigation.
Pialk is a promising surrogate biomarker of mitochondrial content. Thus, the quantification
of Pialk should be sensitive to fiber-type distribution between different muscles (gastrocnemius vs.
soleus (3)). The present study, however, was limited to scans conducted on the belly of the rectus
femoris, which is characterized by a mixed fiber typology. Given that we were able to reliably
quantify Pialk across seven days, it is noteworthy to explore the capability of our present MR study
design to capture changes in Pialk muscles of differing fiber type compositions.
A final experimental consideration of the present study is the duration of the test-retest design:
seven days. Although excellent reproducibility was detected across all metabolites and conditions,
this raises the question if the same would apply to longer longitudinal interventions. For example,
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Layec et al, (2009) revealed ‘very poor’ relative reproducibility, as assessed by ICC, for PCr, Pi,
PDE, and pH in their two-month test-retest design. Further, absolute reproducibility of smaller
peak phosphates was modest (CV: 10-15%) for resonances like Pi. The higher spectral resolution
of the present 3T magnet (as compared to 1.5T in Layec et al., 2009) most likely contributed to
the higher reproducibility of the present study. However, whether longer duration between tests,
as is common for therapeutic monitoring in clinical conditions, may hinder Pialk reproducibility
remains to be explored.
5.4 Conclusion
The present study revealed that Pialk demonstrated an excellent seven-day absolute and relative
reproducibility, similar to larger phosphate metabolites (e.g. PCr). This finding is a pre-requisite
for Pialk to be sensitive to both longitudinal changes (i.e., within-subjects) and cross-sectional
analysis (i.e., between-subject changes). An important aspect to consider is the placement of the
surface coil and sufficient shimming quality. Specifically, sites most distal to the rectus femoris,
associated with lower magnetic field homogeneity in the region of interest, demonstrated
artificially higher Pialk concentrations likely caused by greater overlap between Pialk and Picyt and
resulting in this overestimation. Comparison with prior literature also suggest a benefit of
combining automatic and manual shimming of the signal for optimization of Pi alk linewidth
(FWHM < 15Hz) and more accurate quantification. Provided that sufficient shimming quality is
achieved, the quantification of Pialk using fitting algorithm such as AMARES yield to highly
reproducible results.
Collectively, the present results improve our understanding of the reproducibility of 31P-MRSderived markers by revealing excellent absolute and relative reproducibility across a wide-range
of conditions (e.g., test-retest, spectral processing, measurement procedure, etc.). These results add
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to a limited literature investigating the reproducibility of

31P-MRS.

Importantly, Pialk, a novel

surrogate of mitochondrial content, was also highly reproducible, validating the application of this
biomarker in research and clinical settings. Future studies are still needed to elucidate the
reproducibility of Pialk across longer test-retest conditions (e.g., >7 days) and in clinical
populations (e.g., older adults). This is important given that the application of Pi alk quantification
is most promising in a clinical setting and for therapeutic monitoring.
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